Cleared Traditional

K093566 - CARTO XP EP NAVIGATION SYSTEM, VERSION 10 (FDA 510(k) Clearance)

Jun 2010
Decision
212d
Days
Class 2
Risk

K093566 is an FDA 510(k) clearance for the CARTO XP EP NAVIGATION SYSTEM, VERSION 10. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).

Submitted by Biosense Webster, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on June 18, 2010, 212 days after receiving the submission on November 18, 2009.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.

Submission Details

510(k) Number K093566 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2009
Decision Date June 18, 2010
Days to Decision 212 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DQK — Computer, Diagnostic, Programmable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1425

Similar Devices — DQK Computer, Diagnostic, Programmable

All 45
HemoSphere Nano Monitor (HSNANO1)
K253186 · Edwards Lifesciences, LLC · Feb 2026
CARTO™ 3 EP Navigation System V8.4
K252972 · Biosense Webster, Inc. · Feb 2026
Holter ECG and ABP system (HolterABP)
K251591 · Edan Instruments, Inc. · Feb 2026
CARTO™ 3 EP Navigation System V9.0 with PIU Plus
K254085 · Biosense Webster, Inc. · Jan 2026
LumiGuide Equipment R2.1
K252645 · Philips Medical Systems Nederland B.V. · Oct 2025
EnSite™ X EP System
K252013 · Abbott Medical · Sep 2025